Anika Therapeutics, Inc. financial data

Symbol
ANIK on Nasdaq
Location
Bedford, MA
Fiscal year end
31 December
Latest financial report
03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 543% % -0.51%
Quick Ratio 98% % -38%
Return On Equity -7.4% % 75%
Return On Assets -5.7% % 76%
Operating Margin -9.8% % -130%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13,400,751 shares -5.5%
Common Stock, Shares, Outstanding 13,889,000 shares -3.7%
Entity Public Float $147,343,841 USD -61%
Common Stock, Value, Issued $139,000 USD -3.5%
Weighted Average Number of Shares Outstanding, Basic 14,339,000 shares -2.6%
Weighted Average Number of Shares Outstanding, Diluted 14,339,000 shares -2.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $112,819,000 USD -5.9%
Research and Development Expense $25,770,000 USD 0.88%
Costs and Expenses $74,858,000 USD -7.7%
Operating Income (Loss) $11,051,000 USD -117%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $9,307,000 USD -237%
Income Tax Expense (Benefit) $672,000 USD -89%
Net Income (Loss) Attributable to Parent $10,880,000 USD 81%
Earnings Per Share, Basic -0.76 USD/shares 80%
Earnings Per Share, Diluted -0.76 USD/shares 80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $57,481,000 USD 3.3%
Marketable Securities, Current $23,690,000 USD 0.41%
Accounts Receivable, after Allowance for Credit Loss, Current $23,690,000 USD 0.41%
Inventory, Net $18,787,000 USD -21%
Assets, Current $103,358,000 USD -9.1%
Deferred Income Tax Assets, Net $1,275,000 USD 8.3%
Property, Plant and Equipment, Net $40,324,000 USD 3.4%
Operating Lease, Right-of-Use Asset $25,939,000 USD 0.99%
Intangible Assets, Net (Excluding Goodwill) $1,650,000 USD -34%
Goodwill $8,054,000 USD 13%
Other Assets, Noncurrent $4,034,000 USD -29%
Assets $190,270,000 USD -6.2%
Accounts Payable, Current $6,041,000 USD 7.5%
Employee-related Liabilities, Current $8,658,000 USD 27%
Liabilities, Current $21,908,000 USD -6%
Operating Lease, Liability, Noncurrent $24,196,000 USD 0.76%
Other Liabilities, Noncurrent $701,000 USD -9.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,959,000 USD 27%
Retained Earnings (Accumulated Deficit) $60,787,000 USD -15%
Stockholders' Equity Attributable to Parent $143,465,000 USD -6.8%
Liabilities and Equity $190,270,000 USD -6.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $130,000 USD -3.2%
Net Cash Provided by (Used in) Financing Activities $5,438,000 USD -139%
Net Cash Provided by (Used in) Investing Activities $1,672,000 USD
Common Stock, Shares Authorized 90,000,000 shares 0%
Common Stock, Shares, Issued 15,385,000 shares 2.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,788,000 USD 11%
Deferred Tax Assets, Valuation Allowance $45,581,000 USD 0.96%
Deferred Tax Assets, Gross $59,021,000 USD -0.32%
Operating Lease, Liability $26,248,000 USD 1.2%
Depreciation $5,400,000 USD 8%
Payments to Acquire Property, Plant, and Equipment $2,824,000 USD 56%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $9,056,000 USD 84%
Property, Plant and Equipment, Gross $91,752,000 USD 7.6%
Operating Lease, Liability, Current $2,052,000 USD 7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,772,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,848,000 USD 2.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.037 pure 5.7%
Deferred Income Tax Expense (Benefit) $18,000 USD -91%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,485,000 USD -5.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,772,000 USD 19%
Deferred Tax Assets, Operating Loss Carryforwards $13,294,000 USD 1945%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,250,000 shares 0%
Unrecognized Tax Benefits $300,000 USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,772,000 USD 19%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $400,000 USD -43%
Deferred Tax Assets, Net of Valuation Allowance $13,440,000 USD -4.4%
Share-based Payment Arrangement, Expense $10,996,000 USD -8.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%